Related references
Note: Only part of the references are listed.STING pathway agonism as a cancer therapeutic
Blake A. Flood et al.
IMMUNOLOGICAL REVIEWS (2019)
Therapeutic Targeting of RIG-I and MDA5 Might Not Lead to the Same Rome
Dacquin M. Kasumba et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
Chromosomal instability drives metastasis through a cytosolic DNA response
Samuel F. Bakhoum et al.
NATURE (2018)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
An origin of the immunogenicity of in vitro transcribed RNA
Xin Mu et al.
NUCLEIC ACIDS RESEARCH (2018)
The Abscopal Effect in the Era of Cancer Immunotherapy: a Spontaneous Synergism Boosting Anti-tumor Immunity?
Zuzana Hlavata et al.
TARGETED ONCOLOGY (2018)
Immunological Mechanisms Responsible for Radiation-Induced Abscopal Effect
Maria E. Rodriguez-Ruiz et al.
TRENDS IN IMMUNOLOGY (2018)
cGAS-STING and Cancer: Dichotomous Roles in Tumor Immunity and Development
Kevin W. Ng et al.
TRENDS IN IMMUNOLOGY (2018)
Targeting Cytosolic Nucleic Acid-Sensing Pathways for Cancer Immunotherapies
Sandra Iurescia et al.
FRONTIERS IN IMMUNOLOGY (2018)
A minimal RNA ligand for potent RIG-I activation in living mice
Melissa M. Linehan et al.
SCIENCE ADVANCES (2018)
Therapeutically Active RIG-I Agonist Induces Immunogenic Tumor Cell Killing in Breast Cancers
David L. Elion et al.
CANCER RESEARCH (2018)
撤稿声明: Systematic editing of synthetic RIG-I ligands to produce effective antiviral and anti-tumor RNA immunotherapies (Retraction of Vol 46, Pg 1635, 2018)
Janghyun Lee et al.
NUCLEIC ACIDS RESEARCH (2018)
Regional Differences in Airway Epithelial Cells Reveal Tradeoff between Defense against Oxidative Stress and Defense against Rhinovirus
Valia T. Mihaylova et al.
CELL REPORTS (2018)
Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response
Assaf Marcus et al.
IMMUNITY (2018)
Using immunotherapy to boost the abscopal effect
Wilfred Ngwa et al.
NATURE REVIEWS CANCER (2018)
RNA virus receptor Rig-I monitors gut microbiota and inhibits colitis-associated colorectal cancer
Houbao Zhu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
SB 9200, a novel agonist of innate immunity, shows potent antiviral activity against resistant HCV variants
Meleri Jones et al.
JOURNAL OF MEDICAL VIROLOGY (2017)
UV-induced somatic mutations elicit a functional T cell response in the YUMMER1.7 mouse melanoma model
Jake Wang et al.
PIGMENT CELL & MELANOMA RESEARCH (2017)
cGAS is essential for the antitumor effect of immune checkpoint blockade
Hua Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
The anticancer functions of RIG-I-like receptors, RIG-I and MDA5, and their applications in cancer therapy
Yuanbing Wu et al.
TRANSLATIONAL RESEARCH (2017)
RIG-I Resists Hypoxia-Induced Immunosuppression and Dedifferentiation
Christina Engel et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Nucleic acid-sensing TLRs: trafficking and regulation
Olivia Majer et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
Activation of the MDA-5-IPS-1 Viral Sensing Pathway Induces Cancer Cell Death and Type I IFN-Dependent Antitumor Immunity
Xiaofei Yu et al.
CANCER RESEARCH (2016)
STING Promotes the Growth of Tumors Characterized by Low Antigenicity via IDO Activation
Henrique Lemos et al.
CANCER RESEARCH (2016)
Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer
Qing Chen et al.
NATURE (2016)
Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing
Qi Chen et al.
NATURE IMMUNOLOGY (2016)
The YUMM lines: a series of congenic mouse melanoma cell lines with defined genetic alterations
Katrina Meeth et al.
PIGMENT CELL & MELANOMA RESEARCH (2016)
CpG-induced antitumor immunity requires IL-12 in expansion of effector cells and down-regulation of PD-1
Peng Yin et al.
ONCOTARGET (2016)
Cancer therapies activate RIG-I-like receptor pathway through endogenous non-coding RNAs
Diana Rose E. Ranoa et al.
ONCOTARGET (2016)
Antitumor Activity of cGAMP via Stimulation of cGAS-cGAMPSTING-IRF3 Mediated Innate Immune Response
Tiejun Li et al.
SCIENTIFIC REPORTS (2016)
Activated STING enhances Tregs infiltration in the HPV-related carcinogenesis of tongue squamous cells via the c-jun/CCL22 signal
Liang Ding et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts
David Roulois et al.
CELL (2015)
Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses
Katherine B. Chiappinelli et al.
CELL (2015)
Sequence-Specific Modifications Enhance the Broad-Spectrum Antiviral Response Activated by RIG-I Agonists
Cindy Chiang et al.
JOURNAL OF VIROLOGY (2015)
Diverse roles of STING-dependent signaling on the development of cancer
J. Ahn et al.
ONCOGENE (2015)
STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade
Juan Fu et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Type I interferons in anticancer immunity
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2015)
RIG-I-like helicases induce immunogenic cell death of pancreatic cancer cells and sensitize tumors toward killing by CD8+ T cells
P. Duewell et al.
CELL DEATH AND DIFFERENTIATION (2014)
An evolving arsenal: viral RNA detection by RIG-I-like receptors
Megan E. Fitzgerald et al.
CURRENT OPINION IN MICROBIOLOGY (2014)
STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
Seng-Ryong Woo et al.
IMMUNITY (2014)
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors
Liufu Deng et al.
IMMUNITY (2014)
Therapeutic Efficacy of Bifunctional siRNA Combining TGF-β1 Silencing with RIG-I Activation in Pancreatic Cancer
Jonathan Ellermeier et al.
CANCER RESEARCH (2013)
Master sensors of pathogenic RNA - RIG-I like receptors
Martin Schlee
IMMUNOBIOLOGY (2013)
Mouse, but not Human STING, Binds and Signals in Response to the Vascular Disrupting Agent 5,6-Dimethylxanthenone-4-Acetic Acid
Joseph Conlon et al.
JOURNAL OF IMMUNOLOGY (2013)
A structure-based model of RIG-I activation
Daniel Kolakofsky et al.
RNA (2012)
Targeted Activation of RNA Helicase Retinoic Acid-Inducible Gene-I Induces Proimmunogenic Apoptosis of Human Ovarian Cancer Cells
Kirsten Kuebler et al.
CANCER RESEARCH (2010)
Regulation of Adaptive Immunity by the Innate Immune System
Akiko Iwasaki et al.
SCIENCE (2010)
Sterile inflammation: sensing and reacting to damage
Grace Y. Chen et al.
NATURE REVIEWS IMMUNOLOGY (2010)
5′-triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma
Hendrik Poeck et al.
NATURE MEDICINE (2008)
Recognition of microorganisms and activation of the immune response
Ruslan Medzhitov
NATURE (2007)
The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses
M Yoneyama et al.
NATURE IMMUNOLOGY (2004)